| Gladwin Nursing And Rehabilitation Community | |
| 3270 Pratt Lake Rd, Gladwin, Michigan 48624 | |
| (989) 426-7275 | |
| Name | Gladwin Nursing And Rehabilitation Community |
|---|---|
| Location | 3270 Pratt Lake Rd, Gladwin, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 52.33% |
| Medicare ID (CCN) | 235335 |
| Legal Business Name | Atrium Gladwin, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1225036395 |
| Organization Name | ATRIUM GLADWIN INC. |
| Doing Business As | GLADWIN NURSING AND REHABILITATION COMMUNITY |
| Address | 3270 Pratt Lake Rd, Gladwin, MI 48624 |
| Phone Number | 989-426-7275 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Winner of the Integra Foundation Award, Jeremy Steinberger, MD, presented his research, Morbidity and Mortality of Meningioma Resection Increases in Octogenarians, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Minimally invasive, image-guided treatment is a safe and precise method for removal of self-inflicted foreign objects from the body, according to the first report on "self-embedding disorder," or self-injury and self-inflicted foreign body insertion in adolescents.
The Department of Radiation Oncology at the University of Alabama at Birmingham Comprehensive Cancer Center is among the world's first to begin using radiation technology that dramatically reduces treatment times.UAB's Hazelrig-Salter Radiation Oncology Center is the third U.S. site to acquire TrueBeam technology. TrueBeam, by Varian Medical Systems Inc., can complete a standard 40-minute radiation therapy in less than a minute for select patients. The precision of the instrument, measured in increments of less than a millimeter, comes from real-time patient imaging, positioning, beam shaping and many other data points synchronized continually as treatment progresses.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Winner of the Integra Foundation Award, Jeremy Steinberger, MD, presented his research, Morbidity and Mortality of Meningioma Resection Increases in Octogenarians, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Minimally invasive, image-guided treatment is a safe and precise method for removal of self-inflicted foreign objects from the body, according to the first report on "self-embedding disorder," or self-injury and self-inflicted foreign body insertion in adolescents.
The Department of Radiation Oncology at the University of Alabama at Birmingham Comprehensive Cancer Center is among the world's first to begin using radiation technology that dramatically reduces treatment times.UAB's Hazelrig-Salter Radiation Oncology Center is the third U.S. site to acquire TrueBeam technology. TrueBeam, by Varian Medical Systems Inc., can complete a standard 40-minute radiation therapy in less than a minute for select patients. The precision of the instrument, measured in increments of less than a millimeter, comes from real-time patient imaging, positioning, beam shaping and many other data points synchronized continually as treatment progresses.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $93119 |
| Number of Payment Denials | 2 |
| Total Number of Penalties | 4 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.26 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.88 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.17 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.21 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 10.24 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.85 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.5 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 43.36 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.23 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 30.65 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 10.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.62 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.24 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 82.73 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 92.39 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 65.28 | 82.93 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Winner of the Integra Foundation Award, Jeremy Steinberger, MD, presented his research, Morbidity and Mortality of Meningioma Resection Increases in Octogenarians, during the 2016 American Association of Neurological Surgeons Annual Scientific Meeting.
Minimally invasive, image-guided treatment is a safe and precise method for removal of self-inflicted foreign objects from the body, according to the first report on "self-embedding disorder," or self-injury and self-inflicted foreign body insertion in adolescents.
The Department of Radiation Oncology at the University of Alabama at Birmingham Comprehensive Cancer Center is among the world's first to begin using radiation technology that dramatically reduces treatment times.UAB's Hazelrig-Salter Radiation Oncology Center is the third U.S. site to acquire TrueBeam technology. TrueBeam, by Varian Medical Systems Inc., can complete a standard 40-minute radiation therapy in less than a minute for select patients. The precision of the instrument, measured in increments of less than a millimeter, comes from real-time patient imaging, positioning, beam shaping and many other data points synchronized continually as treatment progresses.
› Verified 9 days ago
Gladwin Nursing And Rehabilitation Community Location: 3270 Pratt Lake Rd, Gladwin, Michigan 48624 Phone: (989) 426-7275 | |
Gladwin Pines Nursing And Rehabilitation Center Location: 449 Quarter Street, Gladwin, Michigan 48624 Phone: (989) 426-3430 |